Leuprolide Acetate Kit
Product Images NDC 70121-2537

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Leuprolide Acetate (NDC 70121-2537). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Leuprolide Acetate Injection 5 mg Per mL 1)

This is a peptide sequence consisting of 10 amino acids. The NHEt at the end suggests that the peptide may have a C-terminal amide group. The specific sequence of amino acids may have biological or pharmacological significance, but without additional context it is impossible to determine its function.*

FDA Label Image

1 (Leuprolide Acetate Injection 5 mg Per mL 10)

FDA Label Image

1 (Leuprolide Acetate Injection 5 mg Per mL 11)

FDA Label Image

1 (Leuprolide Acetate Injection 5 mg Per mL 12)

FDA Label Image

1 (Leuprolide Acetate Injection 5 mg Per mL 13)

FDA Label Image

1 (Leuprolide Acetate Injection 5 mg Per mL 14)

Leuprolide Acetate Injection is a prescription-only medication delivered subcutaneously using a multiple-dose vial. The medication is used at a typical dose of 1 mg/0.2 mL once per day, with each 0.2 mL containing 1mg of Leuprolide acetate USP. The medication should be stored below 25°C/77°F and protected from light. It is important to keep this and all other medications out of the reach of children. Manufacturing license number G/28/1539, distributed by Amneal Pharmaceuticals LLC, and made in India. No information is provided in this text regarding an "Unvamished Area" and "Lot# & Exp. Date," so they are not available.*

FDA Label Image

1 (Leuprolide Acetate Injection 5 mg Per mL 15)

This is a label for Amneal Pharmaceuticals' Leuprolide Acetate Injection, which is used for subcutaneous injection. It is a multiple-dose vial containing 14 mg of medication in 2.8 mL of solution (1 mg per 0.2 mL). Each 0.2 mL dose of the solution contains Leuprolide acetate USP 1 mg with sodium chloride, benzyl alcohol, and water for injection. It is stored below 25°C (77°F) and should be protected from light. It is important to keep this medication out of reach of children. The label provides details on the manufacturer, distributor, and dosage information. *

FDA Label Image

1 (Leuprolide Acetate Injection 5 mg Per mL 16)

This document seems to be a product description for a medication injection kit called Leuprolide Acetate Injection. The kit contains a Leuprolide Acetate vial, disposable syringes, alcohol swabs, and prescribing and administration information. The medication is used for subcutaneous injection and comes in a 14-day patient administration kit. The document also includes information about the dosage, storage instructions, ingredients, and the manufacturer of the medication.*

FDA Label Image

1 (Leuprolide Acetate Injection 5 mg Per mL 2)

FDA Label Image

1 (Leuprolide Acetate Injection 5 mg Per mL 3)

FDA Label Image

1 (Leuprolide Acetate Injection 5 mg Per mL 4)

FDA Label Image

1 (Leuprolide Acetate Injection 5 mg Per mL 5)

FDA Label Image

1 (Leuprolide Acetate Injection 5 mg Per mL 6)

FDA Label Image

1 (Leuprolide Acetate Injection 5 mg Per mL 7)

FDA Label Image

1 (Leuprolide Acetate Injection 5 mg Per mL 8)

FDA Label Image

1 (Leuprolide Acetate Injection 5 mg Per mL 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.